Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
Null hypothesis: 10 IU Oxytocin is better than sublingual misoprostol 600µg in management of
third stage of labor Alternative hypothesis: Sublingual misoprostol 600µg is non- inferior to
10 IU oxytocin and will not be more than 6% worse [than 10 IU oxytocin] in management of
third stage of labor